Edwards Net Receivables from 2010 to 2026
| EW Stock | USD 87.18 0.71 0.82% |
Net Receivables | First Reported 2000-03-31 | Previous Quarter 892.8 M | Current Value 912.1 M | Quarterly Volatility 242.1 M |
Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.9 M, Interest Expense of 15.7 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 4.57, Dividend Yield of 0.0 or PTB Ratio of 4.74. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
Edwards | Net Receivables | Build AI portfolio with Edwards Stock |
The evolution of Net Receivables for Edwards Lifesciences Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Edwards Lifesciences compares to historical norms and industry peers.
Latest Edwards Lifesciences' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Edwards Lifesciences Corp over the last few years. It is Edwards Lifesciences' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edwards Lifesciences' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Edwards Net Receivables Regression Statistics
| Arithmetic Mean | 543,688,529 | |
| Geometric Mean | 492,865,251 | |
| Coefficient Of Variation | 42.68 | |
| Mean Deviation | 193,140,796 | |
| Median | 537,300,000 | |
| Standard Deviation | 232,044,031 | |
| Sample Variance | 53844.4T | |
| Range | 802.7M | |
| R-Value | 0.98 | |
| Mean Square Error | 2735.4T | |
| R-Squared | 0.95 | |
| Slope | 44,843,971 | |
| Total Sum of Squares | 861510.9T |
Edwards Net Receivables History
About Edwards Lifesciences Financial Statements
Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 912.1 M | 957.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.